Skip to main content

Table 2 Summary of patient presentation and outcome

From: Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study

Patient

Location

Size

Central

Stage

Survival

Status

1

LUL

2.9

 

IA

Alive

Hillar failure, to hospice

2

LUL

1.5

 

IA

Alive

No evidence of disease

3

LUL

2.8

Yes

IA

Alive

No evidence of disease

4

RUL

3.5

 

IA

Alive

No evidence of disease

5

LLL

2.3

 

IA

Alive

No evidence of disease

6

LUL

2.2

 

IA

Alive

No evidence of disease

7

LUL

2.3

 

IA

Deceased

Hillar and contralateral failure, hospice

8

LUL

2.4

Yes

IA

Deceased

No evidence of disease

9

LUL

1

 

IA

Deceased

No evidence of disease

10

LUL

5.5

Yes

IB

Alive

No evidence of disease

11

RUL

4

 

IB

Alive

No evidence of disease

12

RUL

4.7

Yes

IB

Alive

No evidence of disease

13

LUL

3

 

IB

Alive

No evidence of disease

14

LLL

3.6

 

IB

Alive

No evidence of disease

15

RML

4.5

Yes

IB

Alive

No evidence of disease

16

RLL

4.3

 

IB

Deceased

Brain metastases, whole brain radiation

17

RML

3.9

 

IB

Deceased

No evidence of disease

18

RLL

3.4

 

IB

Deceased

No evidence of disease

19

LUL

3.9

Yes

IB

Deceased

No evidence of disease

20

RLL

3.1

 

IB

Deceased

No evidence of disease

21

LUL, LUL

1.8, 1.4

 

IA

Alive

No evidence of disease

22

RUL

3.2

 

IA

Alive

Failure in the same lobe, SABR

23

RUL

2

Yes

III

Alive

No evidence of disease

24

LUL

2

 

IA

Deceased

Malignant pleural effusion, hospice

25

LUL

2.2

 

IA

Deceased

Failure at primary and supraclavicular, SABR and tarceva

26

RLL

6.6

 

IB

Deceased

No evidence of disease

27

RLL

3

 

IV

Deceased

No evidence of disease

28

RLL

2.3

 

III

Deceased

Failure in abdominal soft tissue, tarceva

29

LLL

2.3

 

IV

Deceased

No evidence of disease

30

RUL, RML

4, 1.5

 

IV

Deceased

Distant failure in bone, SABR to bone

  1. Therapy at recurrence is noted.